Previous Close | 228.80 |
Open | 229.36 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's Range | 228.25 - 232.98 |
52 Week Range | 148.50 - 232.98 |
Volume | |
Avg. Volume | 532,796 |
Market Cap | 20.562B |
Beta (5Y Monthly) | 0.79 |
PE Ratio (TTM) | 26.65 |
EPS (TTM) | 8.59 |
Earnings Date | Jan 22, 2025 - Jan 27, 2025 |
Forward Dividend & Yield | 5.00 (2.18%) |
Ex-Dividend Date | Sep 16, 2024 |
1y Target Est | 228.23 |
BALL's s third-quarter 2024 results reflect improved segment margins. The company expects to deliver more than mid-single-digit comparable EPS growth in 2024.
ATR's Q3 top line gains from improved performances of the pharma and closures segments.